Enterovirus and Viral Gastroenteritis Unit/National Polio Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Consortium of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Front Cell Infect Microbiol. 2023 May 2;13:1168355. doi: 10.3389/fcimb.2023.1168355. eCollection 2023.
In 2021, a type 2 vaccine-derived poliovirus (VDPV2) was isolated from the stool of a patient with acute flaccid paralysis (AFP) admitted to Spain from Senegal. A virological investigation was conducted to characterize and trace the origin of VDPV2.
We used an unbiased metagenomic approach for the whole-genome sequencing of VDPV2 from the stool (pre-treated with chloroform) and from the poliovirus-positive supernatant. Phylogenetic analyses and molecular epidemiological analyses relying on the Bayesian Markov Chain Monte Carlo methodology were used to determine the geographical origin and estimate the date of the initiating dose of the oral poliovirus vaccine for the imported VDPV2.
We obtained a high percentage of viral reads per total reads mapped to the poliovirus genome (69.5% for pre-treated stool and 75.8% for isolate) with a great depth of sequencing coverage (5,931 and 11,581, respectively) and complete genome coverage (100%). The two key attenuating mutations in the Sabin 2 strain had reverted (A481G in the 5'UTR and Ile143Thr in VP1). In addition, the genome had a recombinant structure between type-2 poliovirus and an unidentified non-polio enterovirus-C (NPEV-C) strain with a crossover point in the protease-2A genomic region. VP1 phylogenetic analysis revealed that this strain is closely related to VDPV2 strains circulating in Senegal in 2021. According to Bayesian phylogenetics, the most recent common ancestor of the imported VDPV2 could date back 2.6 years (95% HPD: 1.7-3.7) in Senegal. We suggest that all VDPV2s circulating in 2020-21 in Senegal, Guinea, Gambia, and Mauritania have an ancestral origin in Senegal estimated around 2015. All 50 stool samples from healthy case contacts collected in Spain (n = 25) and Senegal (n = 25) and four wastewater samples collected in Spain were poliovirus negative.
By using a whole-genome sequencing protocol with unbiased metagenomics from the clinical sample and viral isolate with high sequence coverage, efficiency, and throughput, we confirmed the classification of VDPV as a circulating type. The close genomic linkage with strains from Senegal was consistent with their classification as imported. Given the scarce number of complete genome sequences for NPEV-C in public databases, this protocol could help expand poliovirus and NPEV-C sequencing capacity worldwide.
2021 年,从一名从塞内加尔前往西班牙的急性弛缓性麻痹(AFP)患者的粪便中分离出一株 2 型疫苗衍生脊灰病毒(VDPV2)。进行了病毒学调查,以对 VDPV2 进行特征描述和追踪溯源。
我们使用无偏的宏基因组方法对来自粪便(用氯仿预处理)和脊灰病毒阳性上清液的 VDPV2 进行全基因组测序。使用贝叶斯马尔可夫链蒙特卡罗方法进行系统发育分析和分子流行病学分析,以确定输入性 VDPV2 的地理起源并估计口服脊灰病毒疫苗的起始剂量日期。
我们获得了高比例的病毒读段映射到脊灰病毒基因组的总读段(预处理粪便为 69.5%,分离株为 75.8%),测序深度高(分别为 5931 和 11581),并且完全基因组覆盖率(100%)。Sabin 2 株中的两个关键减毒突变已经恢复(5'UTR 中的 A481G 和 VP1 中的 Ile143Thr)。此外,基因组在 2 型脊灰病毒和一种未识别的非脊灰肠道病毒-C(NPEV-C)株之间具有重组结构,其在蛋白酶-2A 基因组区域存在交叉点。VP1 系统发育分析表明,该株与 2021 年塞内加尔流行的 VDPV2 株密切相关。根据贝叶斯系统发育,输入性 VDPV2 的最近共同祖先可追溯到 2.6 年前(95% HPD:1.7-3.7)在塞内加尔。我们建议 2020-21 年在塞内加尔、几内亚、冈比亚和毛里塔尼亚流行的所有 VDPV2 株均具有约 2015 年在塞内加尔的祖先起源。在西班牙(n=25)和塞内加尔(n=25)收集的 50 名健康病例接触者的粪便样本和在西班牙收集的 4 个污水样本均未检测到脊灰病毒。
通过使用具有高通量、高效率和高序列覆盖度的无偏宏基因组方法对临床样本和病毒分离株进行全基因组测序,我们确认了 VDPV 作为循环型的分类。与来自塞内加尔的株之间的密切基因组联系与其作为输入性株的分类一致。鉴于公共数据库中 NPEV-C 的完整基因组序列数量稀少,该方案有助于扩大脊灰病毒和 NPEV-C 的测序能力。